NCT00205699View on ClinicalTrials.gov

Metabolic Effects of Antipsychotics in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

July 31, 2011

Conditions
AggressionAttention Deficit-HyperactivityOppositional Defiant DisorderPervasive Development DisordersBipolar Disorder
Interventions
DRUG

risperidone

randomized to begin 12 week trial of risperidone

DRUG

olanzapine

randomized to begin 12 week trial of olanzapine

DRUG

aripiprazole

randomized to 12 week trial of aripiprazole

Trial Locations (1)

63110

Washington University School of Medicine, Psychiatry Dept., St Louis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER

NCT00205699 - Metabolic Effects of Antipsychotics in Children | Biotech Hunter | Biotech Hunter